Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hammer

Showing results (81-90 of 82) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 82 results.
Journal of Translational Medicine|March 8, 2022
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous populationJohn D Karalis, Lynn Y Yoon, Suntrea T G Hammer, et al.
Journal of Translational Medicine|September 13, 2024
Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populationsJohn D Karalis, Lynn Y Yoon, Suntrea T G Hammer, et al.
Pageof 9

Showing results (81-90 of 82) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 82 results.
Journal of Translational Medicine|March 8, 2022
Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous populationJohn D Karalis, Lynn Y Yoon, Suntrea T G Hammer, et al.
Journal of Translational Medicine|September 13, 2024
Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populationsJohn D Karalis, Lynn Y Yoon, Suntrea T G Hammer, et al.
Pageof 9